350
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Multiple sclerosis in Caucasians and Latino Americans

, , , &
Pages 571-575 | Received 24 May 2011, Accepted 27 May 2011, Published online: 30 Aug 2011

References

  • Miller A, Lublin F, Coyle P. 2003. History. In: Miller AE, Lublin FD, Coyle PK, Dunitz M. editors. Multiple sclerosis in clinical practice. London: Ed Martin Dunitz1–15.
  • Hafler DA. Multiple sclerosis. Clin Invest. 2004; 113:788–794.
  • Noseworthy J, Lucchinetti C, Rodriguez M, Weinshenker B. Multiple sclerosis. NEJM. 2000; 343:938–952.
  • Bansil S, Cook S, Rohowsky-Kochan C. Multiple sclerosis: Immune mechanism and update on current therapies. Ann Neurol. 2004; 37 S1: 87–101.
  • Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005; 23:683–747.
  • Kasper L, Haque A, Haque S. Regulatory mechanisms of the immune system in multiple sclerosis. T regulatory cells: Turned on to turn off. J Neurol. 2007; 254 Suppl. 1: 110–114.
  • Steinman L. Multiple sclerosis: A two-stage disease. Nature Immunol. 2001; 2:762–764.
  • Trapp B, Peterson J, Ransohoff R, Rudick R, Mork S, Bo L. Axonal transaction in the lesions of multiple sclerosis. N Engl J Med. 1998; 338:278–285.
  • Miller D, Barkhof F, Frank J, Parker G, Thompson A. Measurement of atrophy in multiple sclerosis: Pathological basis, methodological aspects and clinical relevance. Brain. 2002; 125:1676–1695.
  • Warren S, Warren KG. Prevalence of multiple sclerosis in Barrhead County, Alberta Canada. Can J Neurol Sci. 1992; 19:72–75.
  • Rosati G. The prevalence of multiple sclerosis in the world: An update. Neurol Sci. 2001; 2:117–139.
  • Pugliatti M. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg. 2002; 104:182–191.
  • Kurtzke JF. Epidemiology and etiology of multiple sclerosis. Phys Med Rehabil Clin North Am. 2005; 15:327–349.
  • Cristiano E, Patrucco L, Rojas JI. A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol. 2008; 15:11273–11278.
  • Rivera-Olmos VM, Ávila MC. Esclerosis múltiple en Latinoamérica. Son los Criterios de Mc Donald realmente aplicables?. Rev Mex Neurosci. 2007; 8 1: 49–56.
  • Luetic G. MS in Latin America. Int MS J. 2008; 15:6–11.
  • Corona T, Román GC. Multiple sclerosis in Latin America. Neuroepidemiology. 2006; 26:1–3.
  • Melcon MO, Vergara RH, Cerrato R. Prevalencia de Esclerosis Multiple en Junin, Provincia de Buenos Aires, Argentina al 01/01/1991. Rev Neurol Arg. 1994; 19:3–8.
  • Cristiano E, Patrucco L, Garcea O, Carra A, Caceres F. Prevalence of multiple sclerosis (MS) in Argentina using the capture-recapture method. J Neurol Sci. 1999; 52 Suppl. 2: A438.
  • Cristiano E, Patrucco L, Soriano ER, Videla GC, Hares D. Incidence and prevalence of multiple sclerosis in an HMO in Argentina. Mult Scler. 2002; 8:S3.
  • Melcon MO, Gold L, Carrá A, Cáceres F, Correale F. Argentine Patagonia: Prevalence and clinical features of multiple sclerosis. Mult Scler. 2008; 15:656–662.
  • Piedrabuena R, Giobellina R, Alvarez D, Abatedaga V. High prevalence of multiple sclerosis in the city of Oliva, Cordoba, Argentina. Arq Neuropsiquiatr. 2004; 62:13.
  • Callegaro D, de Lolio CA, Radvany J, Tilbery CP, Mendonca RA. Prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, in 1990. Neuroepidemiology. 1992; 11:11–14.
  • Callegaro D, Goldbaum M, Morais L, Tilbery CP, Moreira MA. The prevalence of multiple sclerosis in the city of Sao Paulo. Brazil. Acta Neurol Scand. 2001; 104:208–213.
  • Alvarenga RMM, Santos CMM, Vasconcelos CCF, Poser CM. Multiple sclerosis in Rio de Janeiro. Rev Neurol. 2000; 156 Suppl. 3: 159–160.
  • Rivera VM. Esclerosis múltiple en Latinoamérica. Revista Española de Esclerosis Múltiple. 2008; 9:17–23.
  • Soublette C. Epidemiología en Latino América. Datos Actuales. IV Congreso del Comité Latinoamericano para Tratamiento e Investigación en la Esclerosis Múltiple (LACTRIMS), Isla Margarita, Venezuela, 28 de Junio–1 de Julio de 2006.
  • Pradilla G, León-Sarmiento FE. Esclerosis múltiple en Colombia: Cerrando la brecha. Acta Neurol Colomb. 2007; 23:1–5.
  • Toro J, Sarmiento OL, Diaz del Castillo A, Satizábal CL, Ramírez JD. Prevalence of multiple sclerosis in Bogota, Colombia. Neuroepidemiology. 2007; 28:33–38.
  • Ruiz M, Moscoso M. Pauta de introducción de la esclerosis múltiple en Cuba. Rev Neurol. 2002; 35 12: 1180 (Separata).
  • Lara-Rodriguez R, Rodriguez R, Vargas-Batista A, Fernandez-Carriera R. Clinical and epidemiological study of multiple sclerosis in the capital city of Cuba. Rev Neurol. 2006; 43:16.
  • Abad EP, Pérez M, Alarcón T, Castro E, Díaz F. Epidemiological evidence of multiple sclerosis in Ecuador. Mult Scler. 2008; 14:S55.
  • Abad P, Pérez M, Castro E, Alarcón T, Santibáñez R. Prevalence of multiple sclerosis in Ecuador. Neurología. 2010; 25:309–313.
  • Alter M, Olivares L. Multiple sclerosis in México. Arch Neurol. 1970; 23:451–459.
  • Corona T, Rodríguez LJ, Otero E, Stopp L. Multiple sclerosis in México: Hospital cases at the National Institute of Neurology and Neurosurgery. Neurología. 1996; 11:170–173.
  • Velázquez M, López P, Rivera C. Características epidemiológicas de la esclerosis múltiple en un estado fronterizo con los Estados Unidos de Norteamérica. Arch Neurocien. 2002; 3:147–150.
  • Velázquez M, Macias MA, Rivera OV, Lozano Z. Grupo Mexicano de estudio de la esclerosis múltiple. Rev Neurol. 2003; 36:1019–1022.
  • Arrambide G, de la Maza M, Perez-Zuno JA, Duriez E, Dondis D, Avila M. The prevalence of multiple sclerosis in the city of San Pedro GG, Mexico. Arq Neuro-Psiquiatr. 2004; 62:11.
  • Gracia F, Castillo LC, Benzadón A, Larreategui M, Vilarreal F. Prevalence and incidence of multiple sclerosis in Panama (2000–2005). Neuroepidemiology. 2009; 32:287–293.
  • Sanchez LP, Fiol M, Cedo P. Multiple sclerosis in Puerto Rico (experience at the University Hospital): Review of series of cases. Bol Asoc Med PR. 1972; 64:176–178.
  • Ketzoian C, Oehninger C, Alcantaran J. Estudio de la prevalencia de la esclerosis multiple en Uruguay. Acta Neurol Colomb. 1999; 15:6.
  • Gonzalez O, Sotelo J. Is the frequency of multiple sclerosis increasing in Mexico?. JNNP. 1995; 59:528–530.
  • Rivera VM. Multiple sclerosis in Latin America. Reality and challenge. Neuroepidemiology. 2009; 32:294–295.
  • Lizcano Fernández Francisco. Composición étnica de las tres áreas culturales del Continente Americano al comienzo del siglo XXI. Convergencia. 2005; 12 38: 185–232 Universidad Autónoma del Estado de México. ISSN 1405–35.
  • Rivera VM, Landero S. Multiple sclerosis in Mexican American population. Int J MS Care. 2005/2006; 7:143–147.
  • Poser CM. 1998. Multiple sclerosisPoser CM. New York: Phartenon Publishing Group16–18.
  • Correale J. MS in Latin America. Int MS J. 2008; 15:3–5.
  • Alves-Leon SV, Papais-Alvarenga R, Magalhães M, Alvarenga M, Thuler LC, Fernández y Fernandez O. Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand. 2007; 115 5: 306–311.
  • Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol. 2007; 61 2: 97–108.
  • Lana-Peixoto MA, Lana-Peixoto MI. Is multiple sclerosis in Brazil and Asia alike?. Arq Neuropsiquiatr. 1992; 50:419–425.
  • Patrucco L, Cristiano E Videla GC, Bauso Toselli Pl. Devic's neuromyelitis optica (NMO) and multiple sclerosis (MS); Clinical and epidemiological findings in a MS center in Argentina. Mult Scler. 2002; 8:S37.
  • Rodríguez A, Sotelo J. Esclerosis múltiple en México. Sal Públ Méx. 1981; XXIII:451–456.
  • Sánchez JL, Palacio LG, Uribe CS, Londoño AC, Villa A, Jiménez M, Anaya JM, Jiménez I, Camargo M, Arcos-Burgos M. Clinical features of multiple sclerosis in a genetically homogeneous tropical population. Mult Scler. 2001; 7:227–228.
  • Cordova J, Vargas S, Sotelo J. Western and Asian features of multiple sclerosis in Mexican Mestizos. Clin Neurol Neurosurg. 2007; 109:146–151.
  • Arberas C, Cáceres F, Fernández-Liguori N, Saladino L, Romanin V. Formas familiares de esclerosis múltiple en una cohorte de pacientes en la república Argentina. Rev Neurol. 2006; 43:15.
  • Paty D, Studney D, Redekop K, Lublin F. Managing individuals with multiple sclerosis MS COSTAR: A computerized patient record adapted for clinical research purposes. Ann Neurol. 1994; 36:134–135.
  • Etzensperger R, Mc Mahon RM, Jones EY, Fugger L. Dissection of multiple sclerosis associated DR2 haplotype. J Autoimmun. 2008; 31:201–207.
  • Alvarado de la Barrera C, Zúñiga-Ramos J, Ruiz-Morales JA, Estañol B, Granados J, Llorente L. HLA class II genotypes in Mexican Mestizos with familial and non familial multiple sclerosis. Neurology. 2000; 55:1897–1900.
  • Rojas OL, Rojas-Villarraga A, Cruz-Tapias P, Sánchez JL, Suárez-Escudero JC, Patarrollo MA, . Latin American patients with multiple sclerosis. Autoimmun Rev. 2010; 9 6: 407–413.
  • Sanchez JL, Londoño AC, Palacio B, Arcos-Burgos M, Villa A, Jimenez M, Anaya JM, Uribe C, Jimenez I. Esclerosis múltiple: Aproximación epidemiológico-genética en habitantes de Antioquia Colombia. Acta Neurol Colomb. 1998; 14:33–38.
  • Aláez C, Corona T, Ruano L, Flores H, Loyola L, Gorodezky C. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans. Acta Neurol Scand. 2005; 112:317–322.
  • Gorodezky C, Castro-Escobar LE, Escobar-Gutierrez A. HLA system in the prevalent Mexican Indian group: The Nahuas. Tissue Antigens. 1985; 25:38–46.
  • Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003; 2:117–127.
  • Ruth AM. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004; 3:709–718.
  • Fleming JO, Cook TD. Multiple sclerosis and the hygiene hypothesis. Neurology. 2006; 67:2085–2086.
  • Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989; 299:1259–1260.
  • Gold DR, Wright R. Population disparities in asthma. Ann Rev Publ Health. 2005; 26:89–113.
  • Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004; 3:709–718.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.